Literature DB >> 1357570

Estradiol regulation of somatostatin receptors in the arcuate nucleus of the female rat.

A Slama1, C Videau, C Kordon, J Epelbaum.   

Abstract

Somatostatin receptors on lactotroph cells of the anterior pituitary are positively regulated by estradiol. In the present work, we investigated whether estradiol regulation of somatostatin receptors also occurred in the female rat brain. 125I-Tyr0-DTrp8-somatostatin (125I-SRIF: 780 Ci/mM) was used as a ligand. Female adult rats were ovariectomized and treated or not with estradiol benzoate (20 micrograms/day for 1 or 8 days). In female brains, 125I-SRIF binding, as assessed by film radioautography, was high in the basolateral amygdala, CA1 field and dentate gyrus of the hippocampus and locus coeruleus, moderate in the median habenula and deep layers all through the cortex. Castration or estradiol treatment did not modify 125I-SRIF binding in these regions. By light-microscopic radioautography, a subpopulation of 125I-SRIF-labeled cells was localized in the ventrolateral portion of the arcuate nucleus. Ovariectomy alone did not significantly affect the number and binding density of 125I-SRIF-labeled cells in the arcuate nucleus. However, estradiol treatment in ovariectomized animals significantly increased both parameters. Along the estrus cycle, the number of 125I-SRIF-labeled cells was not significantly modified but 125I-SRIF binding density was significantly higher in proestrus as compared to diestrus I, diestrus II and estrus. These results demonstrate that brain 125I-SRIF binding sites are positively regulated by estradiol only in the arcuate nucleus of the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357570     DOI: 10.1159/000126234

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

Review 1.  Anatomy of the hypophysiotropic somatostatinergic and growth hormone-releasing hormone system minireview.

Authors:  Mariann Fodor; Claude Kordon; Jacques Epelbaum
Journal:  Neurochem Res       Date:  2006-04-04       Impact factor: 3.996

Review 2.  Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours.

Authors:  Samuel Adant; Girish M Shah; Jean-Mathieu Beauregard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-06       Impact factor: 9.236

3.  Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adenborduin Adeniji; John M Miles; Remberto Paulo; Mihaela Cosma; Cacia Soares-Welch
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

4.  Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women.

Authors:  Mihaela Cosma; Joy Bailey; John M Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

5.  Early cerebral activities of the environmental estrogen bisphenol A appear to act via the somatostatin receptor subtype sst(2).

Authors:  Rosa Maria Facciolo; Raffaella Alò; Maria Madeo; Marcello Canonaco; Francesco Dessì-Fulgheri
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.